CATEGORY
WHO
- ABPI
- ACE
- ACIS
- Adelaide
- Aetsa
- Agenas
- AHRQ
- AIFA
- AMNOG
- ANVISA
- AOTMiT
- AQuAS
- Behandlingsraadet
- BfArM
- Biocat
- C2H
- CADTH
- CDC
- CDE
- CMS
- COFEPRIS
- CONITEC
- Digemid
- EFPIA
- EMA
- EPF
- Eucope
- EUnetHTA
- EuropaBio
- European Commission
- Euskadi
- FDA
- FOPH
- G-BA
- Gesundheit Österreich
- HAS
- Health Technology Wales
- Healthcare Improvement Scotland
- HHS
- HIQA
- HTAi
- ICER
- IECS
- IETS
- IHE
- IHEA
- INAHTA
- IQWiG
- ISPOR
- KCE
- Medicaid
- Medicines for Europe
- MHRA
- MSP
- NECA
- NHS
- nHTA
- NICE
- NIH
- NIHO
- NIHR
- NIPH
- NSW Health
- NZa
- OHE
- OYS
- PBS
- pCPA
- Pharmac
- PhRMA
- Salute
- SBU
- Schönermark Kielhorn Collegen
- SGK
- TÄ°TCK
- TLV
- WHO
- ZonMw
- Zorginstituut Nederland
WHO Endorses First Single-Dose Treatment for P. vivax Malaria
EPF Empowers Patient Groups with New Anti-AMR Toolkit
Korea and WHO Discuss Future Health Security at Bio Summit
Regulators Push for Coordinated Mpox Vaccine Trials
G-BA Approves Updates to COVID-19 Vaccination Guidelines
Johnson & Johnson’s New Data Highlights Promising Neuropsychiatry Advances
G-BA Greenlights Clinical Trial for Novel Pancreatic Cancer Treatment
Roche’s Evrysdi Shows Promising Results in Early SMA Treatment for Infants
WHO Calls for Key Data on COVID-19 Vaccine Antigen Composition Ahead of December 2024 Deliberations
Germany Shifts Influenza Vaccination Strategy to Trivalent Formulations for 2024
Cervical Cancer Prevention Guidelines Updated by WHO to Include Roche’s Dual-Stain Test
WHO Endorses Dual-Stain Cytology for Cervical Cancer Screening
UNICEF Issues Emergency Tender for Mpox Vaccines in Crisis-Hit Countries